WeVote

Bill

Bill

SB 474

Health Insurance - Adverse Decisions - Notices, Reporting, and Examinations

2025 Regular Session Introduced by Pam Beidle

Maryland law now requires insurers to issue detailed denial notices and report adverse coverage decisions annually to state regulators for oversight and transparency.

Approved by the Governor - Chapter 670
0
WeVote Research Nonpartisan
Bill Summary · SB 474

Legislative bill overview

SB 474 requires health insurance companies to provide detailed written notices to policyholders when denying, limiting, or delaying coverage decisions, and mandates that insurers report adverse decision data to the Maryland Insurance Commissioner annually. The bill also establishes examination authority for the Commissioner to review insurers' decision-making practices and compliance with notice requirements.

Why is this important

Health insurance denials can have serious consequences for patients' medical care and finances. This transparency requirement helps consumers understand why they were denied coverage and gives regulators visibility into patterns of denials that might indicate problematic insurer practices. Better oversight could protect consumers from arbitrary or systematic coverage denials while holding insurers accountable.

Potential points of contention

  • Compliance costs: Insurance companies may argue that detailed notice requirements and annual reporting increase administrative burden and costs, which could potentially be passed to consumers through higher premiums
  • Regulatory scope: Some may question whether the Insurance Commissioner's examination authority is sufficiently defined or could lead to overly broad regulatory intrusion into business operations
  • Definition clarity: The bill's definitions of what constitutes an "adverse decision" could create disputes about which denials require notices, potentially leading to inconsistent implementation

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.